References
- Jones S R, Myers E N, Barnes L. Benign neoplasms of the larynx. Otolaryngol Clin North Am 1984; 17: 151–78
- Dikkets F G, Schutte HK. Benign lesions of the vocal folds: uniformity in assessment of clinical diagnosis. Clin Otolaryngol 1991; 16: 8–11
- Moll R, Franke W W, Schiller D L, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982; 31: 11–24
- Kasper M, Stosiek P. The expression of vimentin in epithelial cells from human nasal mucosa. Eur Arch Otorhinolaryngol 1990; 248: 53–6
- Ramaekers F CS, Smedts F, Vooijs GP. Keratins as differentiation markers in tumor biology and surgical pathology. Current perspectives on molecular and cellular oncology., DA Spandidos. JAI Press, London 1992; 285–318
- van der Velden L A, Schaafsma H E, Manni J J, Ramaekers F C, Kuijpers W. Cytokeratin expression in normal and (pre)malignant head and neck epithelia: an overview. Head Neck 1993; 15: 133–46
- Morgan P R, Su L. Intermediate filaments in oral neoplasia. I. Oral cancer and epithelial dysplasia. Eur J Cancer 1994; 30: 160–6
- Su L., Morgan PR, Lane EB. Protein and mRNA expression of simple epithelial keratins in normal, dys-plastic, and malignant oral epithelia. Am J Pathol 1994; 145: 1349–57
- Morgan P R, Shirlaw P J, Johnson N W, Leigh I M, Lane EB. Potential applications of anti-keratin antibodies in oral diagnosis. J Oral Pathol 1987; 16: 212–22
- Steinberg B M, Abramson A L, Kahn L B, Hirschfield L, Freiberger I. Vocal cord polyps: biochemical and histologic evaluation. Laryngoscope 1985; 95: 1327–31
- Fitz-Hugh G S, Smith D E, Chiong AT. Pathology of three hundred clinically benign lesions of the vocal cord. Laryngoscope 1958; 68: 855–75
- Loire R, Bouchayer M, Cornut G, Bastian RW. Pathology of benign vocal fold lesions. Ear Nose Throat J 1988; 67: 360–2; 357–8
- Schaafsma H E, Ramaekers F C, van Muijen G N, et al. Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression. Am J Pathol 1990; 136: 329–43
- Smedts F, Ramaekers F, Robben H, et al. Changing patterns of keratin expression during progression of cervical intraepithelial neoplasia. Am J Pathol 1990; 136: 657–68
- Heyden A, Huitfeldt H S, Koppang H S, Thrane P S, Bryne M, Brandtzaeg P. Cytokeratins as epithelial differentiation markers in premalignant and malignant oral lesions. J Oral Pathol Med 1992; 21: 7–11
- Markey A C, Lane E B, Churchill L J, MacDonald D M, Leigh IM. Expression of simple epithelial keratins 8 and 18 in epidermal neoplasia [see comments]. J Invest Dermatol 1991; 97: 763–70
- Purkis P E, Steel J B, Mackenzie I C, Nathrath W B, Leigh I M, Lane EB. Antibody markers of basal cells in complex epithelia. J Cell Sci 1990; 97: 39–50
- Cooper D, Schermer A, Sun TT. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications, and limitations. Lab Invest 1985; 52: 243–56
- Thewes M, Stadler R, Korge B, Mischke D. Normal psoriatic epidermis expression of hyperproliferation-as-sociated keratins. Arch Dermatol Res 1991; 283: 465–71
- Troyanovsky S M, Guelstein V I, Tchipysheva T A, Kru-Tovskikh V A, Bannikov GA. Patterns of expression of keratin 17 in human epithelia: dependency on cell position. J Cell Sci 1989; 93: 419–26
- De Jong E MGJ, van Vlijmen I MMJ, van Erp P EJ, Ramaekers F CS, Troyanovski S M, van De Kerkhof P CM. Keratin 17: a useful marker in anti-psoriatic therapies. Arch Dermatol Res 1991; 283: 480–2
- Kasper M, Karsten U, Stosiek P, Moll R. Distribution of intermediate-filament proteins in the human enamel organ: unusually complex pattern of coexpression of cytokeratin polypeptides and vimentin. Differentiation 1989; 40: 207–14
- Stasiak P C, Purkis P E, Leigh I M, Lane EB. Keratin 19: predicted amino acid sequence and broad tissue distribution suggest it evolved from keratinocyte keratins. J Invest Dermatol 1989; 92: 707–16
- Lindberg K, Rheinwald JG. Suprabasal 40 kd keratin (K19) expression as an immunohistologic marker of premalignancy in oral epithelium. Am J Pathol 1989; 134: 89–98
- Copper M P, Braakhuis B J, De Vries N, van Dongen G A, Nauta J J, Snow GB. A panel of biomarkers of carcinogenesis of the upper aerodigestive tract as potential intermediate endpoints in chemoprevention trials. Cancer 1993; 71: 825–30